Bristol-Myers Squibb Co (NYSE: BMY) has seen a decline in its stock price by -4.97 in relation to its previous close of 50.06. However, the
Bristol-Myers Squibb Co (NYSE: BMY) has a price-to-earnings ratio that is above its average at 18.99x. The stock has a 36-month beta value of 0.41.
The price-to-earnings ratio for Bristol-Myers Squibb Co (NYSE: BMY) is above average at 17.98x. The 36-month beta value for BMY is also noteworthy at 0.42.
The stock of Bristol-Myers Squibb Co (BMY) has gone down by -2.44% for the week, with a -18.06% drop in the past month and a
In the past week, BMY stock has gone down by -8.30%, with a monthly decline of -15.88% and a quarterly plunge of -9.17%. The volatility
The stock of Bristol-Myers Squibb Co (BMY) has seen a -7.86% decrease in the past week, with a -8.11% drop in the past month, and
The stock of Bristol-Myers Squibb Co (BMY) has seen a -1.72% decrease in the past week, with a 2.07% gain in the past month, and
Company’s 36-month beta value is 0.42.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 4 as “overweight,” 18 as
Company’s 36-month beta value is 0.42.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 4 as “overweight,” 18 as
© 2024, Powered by Smart TechOne
